Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iannis Aifantis

Showing results (161-170 of 206) with videos related to

Pageof 21
Sort By:
Cell|August 9, 2023
A membrane-associated MHC-I inhibitory axis for cancer immune evasionXufeng Chen, Qiao Lu, Hua Zhou, et al.
Cancer Cell|August 18, 2012
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repressionOmar Abdel-Wahab, Mazhar Adli, Lindsay M LaFave, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A K27-linked Ubiquitin Checkpoint Controls NOTCH HomeostasisBehzad Mansoori, Ying Song, Tian Zhang, et al.
Cell Reports|December 12, 2019
A Deep Learning Framework for Predicting Response to Therapy in CancerTheodore Sakellaropoulos, Konstantinos Vougas, Sonali Narang, et al.
Blood|May 22, 2025
CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAsEugenio Morelli, Anil Aktas-Samur, Domenico Maisano, et al.
Nature Cancer|January 19, 2023
Author Correction: An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemiaAudrey Lasry, Bettina Nadorp, Maarten Fornerod, et al.
Cancer Cell|July 5, 2011
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformationKelly Moran-Crusio, Linsey Reavie, Alan Shih, et al.
Cell Stem Cell|August 30, 2016
MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control HematopoiesisBeatriz Aranda-Orgilles, Ricardo Saldaña-Meyer, Eric Wang, et al.
Nature Cancer|December 29, 2022
An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemiaAudrey Lasry, Bettina Nadorp, Maarten Fornerod, et al.
Cancer Discovery|February 25, 2017
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma CellsEster Valls, Camille Lobry, Huimin Geng, et al.
Pageof 21

Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
Cell|August 9, 2023
A membrane-associated MHC-I inhibitory axis for cancer immune evasionXufeng Chen, Qiao Lu, Hua Zhou, et al.
Cancer Cell|August 18, 2012
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repressionOmar Abdel-Wahab, Mazhar Adli, Lindsay M LaFave, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A K27-linked Ubiquitin Checkpoint Controls NOTCH HomeostasisBehzad Mansoori, Ying Song, Tian Zhang, et al.
Cell Reports|December 12, 2019
A Deep Learning Framework for Predicting Response to Therapy in CancerTheodore Sakellaropoulos, Konstantinos Vougas, Sonali Narang, et al.
Blood|May 22, 2025
CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAsEugenio Morelli, Anil Aktas-Samur, Domenico Maisano, et al.
Nature Cancer|January 19, 2023
Author Correction: An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemiaAudrey Lasry, Bettina Nadorp, Maarten Fornerod, et al.
Cancer Cell|July 5, 2011
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformationKelly Moran-Crusio, Linsey Reavie, Alan Shih, et al.
Cell Stem Cell|August 30, 2016
MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control HematopoiesisBeatriz Aranda-Orgilles, Ricardo Saldaña-Meyer, Eric Wang, et al.
Nature Cancer|December 29, 2022
An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemiaAudrey Lasry, Bettina Nadorp, Maarten Fornerod, et al.
Cancer Discovery|February 25, 2017
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma CellsEster Valls, Camille Lobry, Huimin Geng, et al.
Pageof 21